Navigation Links
STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000
Date:5/3/2011

r after the call's conclusion and will be available for seven days. This replay can be accessed by dialing 800-406-7325 for domestic callers and 303-590-3030 for international callers, both using passcode 4434620#. To access the live webcast of the call, go to STAAR's website at www.staar.com. An archived webcast will also be available at www.staar.com.

About STAAR SurgicalSTAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye.  All of these lenses are foldable, which permits the surgeon to insert them through a small incision.  A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL."  A lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL."  Over 200,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com.  STAAR has approximately 300 full time employees and markets lenses in approximately 50 countries.  Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA.  For more information, please visit the Company's website at www.staar.com or call 626-303-7902.  

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material.  

Safe HarborAll statements in this press release that are not statements of historical fact are forward-looking statements, including statements about any of the following: projections of earnings, revenue, sales, profit margins, cash or any other financial items; the plans, strategies, and objectives of management for future operati
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
2. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
3. STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter
4. STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS
5. STAAR Surgical Reports Continued Double Digit Core Revenue Growth
6. STAAR Surgicals Visian® ICL Surpasses 200,000 Implants
7. STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million
8. STAAR Surgical Enters Into Distribution Agreement With Ellex in Australia
9. STAAR Surgical Launches Second Phase of Visian ICL Direct-to-Consumer Advertising Campaign
10. STAAR Surgicals nanoFLEX™ Collamer® IOL Receives CE Mark Approval
11. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... -- Research and Markets has announced ... Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study ... devices. The report provides a basic ... and industry chain structure. The laparoscopic devices market ...
(Date:9/16/2014)... 2014 On September 25 to 26, 2014, ... medical design and manufacturing - MEDTEC China  - will ... Exhibition & Convention Center, bringing together close to 300 ... showcase their latest medical-grade raw materials, parts and processing ... remaining for free visitor pre-registration to be completed. To ...
(Date:9/16/2014)... -- Northwest Biotherapeutics (NASDAQ: NWBO ) ("NW ... for solid tumor cancers, announced today that its DCVax-L ... a "Promising Innovative Medicine" (PIM) under the new "Early ... in April 2014.  A PIM is the first step ... the EAMS.  The PIM designation for ...
Breaking Medicine Technology:Global Laparoscopy Devices Industry Report 2014 2MEDTEC China 2014: Seven Highlights Not to Miss! 2MEDTEC China 2014: Seven Highlights Not to Miss! 3MEDTEC China 2014: Seven Highlights Not to Miss! 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 3NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 5
... YORK, Sept. 22, 2011 Reportlinker.com ... report is available in its catalogue: ... Contract Pharmaceutical Manufacturing, Research And Packaging: ... http://www.reportlinker.com/p0619263/Global-Markets-for-Contract-Pharmaceutical-Manufacturing-Research-And-Packaging-Focus-on-Emerging-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Manufacturing ...
... announces that a new market research report is ... Drugs: The Global Market--Focus on Asia ... REPORT CONTAINS * An examination ... generics to meet the challenges of this highly ...
Cached Medicine Technology:Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 2Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 3Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 4Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 5Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 6Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 7Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 8Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 9Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 10Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 11Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 12Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 13Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 14Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 15Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 16Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets 17Generic Drugs: The Global Market--Focus on Asia 2Generic Drugs: The Global Market--Focus on Asia 3Generic Drugs: The Global Market--Focus on Asia 4Generic Drugs: The Global Market--Focus on Asia 5Generic Drugs: The Global Market--Focus on Asia 6Generic Drugs: The Global Market--Focus on Asia 7Generic Drugs: The Global Market--Focus on Asia 8Generic Drugs: The Global Market--Focus on Asia 9
(Date:9/16/2014)... Kathleen Doheny HealthDay Reporter ... simple urine test can routinely spot human papillomavirus (HPV), which ... analysis found. "Our study shows that testing urine for ... from the cervix for HPV," said lead researcher Dr. Neha ... research fellow at Queen Mary University of London, England. ...
(Date:9/16/2014)... Orlando, Florida (PRWEB) September 16, 2014 These ... the last 3 years to receive up to $10,000 in ... This program, as well as other state and federal programs, ... have to be paid back until you sell or move ... loan is a 0% interest loan. There are no monthly ...
(Date:9/16/2014)... 14, 2014 A new study found that ... stenting of true coronary bifurcation lesions yields similar ... DKCRUSH-VI clinical trial is the first study to ... were reported today at the 26th annual Transcatheter ... Cardiovascular Research Foundation (CRF), TCT is the world,s ...
(Date:9/16/2014)... Programs and policies that promote health ... of dollars in savings for the US health system, ... To help spur these types of improvements, the National ... groups from across the country to field test the ... a handbook designed to assist groups working together to ...
(Date:9/16/2014)... 16, 2014 As part of its ... American Citizens (LULAC) will host the second annual health ... will feature free health screenings for osteoporosis, HIV, and ... glucose and cholesterol levels as well as bone marrow ... children under 6 years old , The event will ...
Breaking Medicine News(10 mins):Health News:Urine Test for HPV Works Well, Analysis Finds 2Health News:New Updated 2014 First Time Home Buyer Programs Available to Florida Residents 2Health News:New Updated 2014 First Time Home Buyer Programs Available to Florida Residents 3Health News:Results of DKCRUSH-VI trial reported at TCT 2014 2Health News:NQF Seeks Field Testing Groups for Population Health Guide 2Health News:NQF Seeks Field Testing Groups for Population Health Guide 3Health News:LULAC Hosts Second Annual Latinos Living Healthy Feria de Salud in Los Angeles 2
... , , WARRENVILLE, Ill., Aug. 5 ... ) is reaching out to key members of Congress to offer ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090804/UCAOALOGO ) ... care is a critical part of any patient-centered health care system, ...
... , , , ... Barrett has been elected to the company,s board of directors and will ... the completion of the planned spinoff of CareFusion Corp. on Aug. 31. ... chief executive officer of the company,s Healthcare Supply Chain Services segment since ...
... , Sen. Sherrod Brown, Public Health Insurance ... Reform Stand, Need To Hold Insurers Accountable , , ... will join health care expert Jacob Hacker and Campaign for ... call Thursday morning to brief reporters on a new analysis that shows ...
... , , BOSTON, Aug. ... a proposed $41.5 million settlement with drug manufacturers Merck & ... SGP ) to settle allegations the companies suppressed ... Vytorin and Zetia. Merck and Schering-Plough previously settled similar ...
... MaxLife Fund Corp. (OTC:MXFD), have announced that some of ... of 14,050,000 shares of the Company,s common stock in ... , Bennett Kurtz, Chief Executive Officer of the Company ... for our Company to increase shareholder value and support ...
... ... of prime labels with new site enhancements. The site enhancements provide customers with a ... , ... (PRWEB) August 5, 2009 -- My1Stop.com, the commercial printing superstore, launched upgraded prime label ...
Cached Medicine News:Health News:Urgent Care Association of America Launches Program to Educate Congress on Urgent Care 2Health News:George Barrett Named Chairman and CEO of Cardinal Health 2Health News:George Barrett Named Chairman and CEO of Cardinal Health 3Health News:George Barrett Named Chairman and CEO of Cardinal Health 4Health News:Sen. Brown, Hacker, to Release New Paper On How Public Plan in House and Senate Bills Measure Up 2Health News:Hagens Berman Sobol Shapiro: Vytorin and Zetia Makers Settle Class-Action Suit With Proposed $41.5 Million 2Health News:Hagens Berman Sobol Shapiro: Vytorin and Zetia Makers Settle Class-Action Suit With Proposed $41.5 Million 3Health News:MaxLife Fund Corp. announces cancellation of 14,050,000 Common Shares 2Health News:My1Stop.com Completes Upgrades to Prime Labels Offering and Easy Ordering Page Design 2
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Micro emulsifying needles, 18G....
Micro 2000, micro scissors micro 2000 supercut....
Yasargil clip applying forceps Mini. Stainless steel jaw....
Medicine Products: